|
NMT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.95503679490639E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.782800E-01 |
| Stage1-vs-Stage3 |
4.235200E-01 |
| Stage1-vs-Stage4 |
1.886190E-02 |
| Stage2-vs-Stage3 |
4.269200E-01 |
| Stage2-vs-Stage4 |
3.535600E-02 |
| Stage3-vs-Stage4 |
1.060590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.31199964623374E-10 |
| Normal-vs-Asian |
1.71329617160154E-12 |
| Caucasian-vs-AfricanAmerican |
4.650000E-01 |
| Caucasian-vs-Asian |
5.223600E-01 |
| AfricanAmerican-vs-Asian |
8.201800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.601200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.38139999999954E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.497400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.986800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.644400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.046000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.241400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.269200E-01 |
| Classical-VS-Follicular |
3.519300E-03 |
| Classical-VS-Other |
8.014800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.872400E-01 |
| Tall-VS-Other |
9.485200E-01 |
| Tall-VS-Normal |
2.75546252481718E-12 |
| Follicular-VS-Other |
7.208400E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
4.796000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.55111512312578E-16 |
| N0-vs-N1 |
1.463580E-01 |
|
|
